Ensuring Sufficient Supply of Testing Act

HR 3840, the Ensuring Sufficient Supply of Testing Act, amends the Public Health Service Act to allow the federal government to directly contract with clinical laboratories for testing supplies through the Strategic National Stockpile. This change expands existing contracting authority, which previously only covered vendors, manufacturers, or distributors, to explicitly include clinical laboratories. The bill directly affects clinical laboratories by creating a new pathway for them to supply testing materials to the federal stockpile. It makes no substantive policy changes but clarifies procurement mechanisms for pandemic preparedness.